Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay

Modern Pathology

Volumn 15, Issue 2, 2002, Pages 159-166

  De Preter, Katleen ^a   Speleman, Frank ^a   Combaret, Valérie ^b   Lunec, John ^c   Laureys, Geneviève ^a   Eussen, Bert H J ^d   Francotte, Nadine ^e   Board, Julian ^c   Pearson, Andy D J ^c   De Paepe, Anne ^a   Van Roy, Nadine ^a   Vandesompele, Jo ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CENTRE LÉON BÉRARD   (France)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e Service De Chirurgie Pédiatrique   (Belgium)

Author keywords

DDX1 amplification; MYCN amplification; NAG amplification; Neuroblastoma; Real time quantitative PCR; Survival; SYBR Green I

Indexed keywords

DNA; DYE; GENE PRODUCT; ONCOPROTEIN; PROTEIN DDX1; PROTEIN NAG; SYBR GREEN 1; TAQ POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE NUMBER; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

DEAD-BOX RNA HELICASES; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; REPRODUCIBILITY OF RESULTS; RNA HELICASES; SURVIVAL ANALYSIS;

EID: 18244397746     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880508     Document Type: Article

References (26)

1. Molecular biology of neuroblastoma
2. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
3. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study
4. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
5. Detection of N-myc gene amplification by fluorescence in sim hybridization. Diagnostic utility for neuroblastoma
6. Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma
7. Detection of MYCN amplification in neuroblastoma using competitive PCR quantitation
8. MYCN amplification by differential PCR
9. Kinetic PCR. Analysis: Real-time monitoring of DNA amplification reactions
10. Real-time quantitative PCR
11. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines
12. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma
13. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma
14. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma
15. 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines
16. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma
17. Analysis of candidate gene co-amplification with MYCN in neuroblastoma
18. Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols
19. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
20. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction
21. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow guidelines
22. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer
23. Advances in quantitative PCR technology: 5′ Nuclease assays
24. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system
25. Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma
26. The DDX1 gene which is frequently co-amplified with MYCN in primary neuroblastoma is itself tumourigenic